Transgender people
Introduction
Men who have sex with men (MSM) and transgender women (TGW) are at increased risk for acquiring HIV, but there are limited HIV incidence data for these key populations in Africa.
UNAIDS warmly welcomes the announcement that the long-acting injectable cabotegravir is safe and effective in preventing HIV among gay men and other men who have sex with men and transgender women.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc.
Background
In 2018, the global distribution of new HIV infections in 2018 crossed a threshold: the majority of global new infections were among key populations and their sexual partners. This change is a result of the strong progress in settings with high HIV prevalence in eastern and southern Africa, combi
The Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project developed an enhanced peer outreach approach (EPOA) t
For pre-exposure prophylaxis (PrEP) to have a substantial public health impact, access to PrEP needs to be improved so that more people who would benefit from it receive PrEP. Services need to adapt and innovate.